November 25, 2018
In-licensing may be pharma’s preferred mode of business development these days. Should that impact your investment strategy?
October 14, 2018
A look at 10 drugs going off patent in 2018, plus an overview of what loss of exclusivity means for...
July 29, 2018
resTORbio, ADMA Biologics, Misonix, Novus Therapeutics and Innovate Biopharmaceuticals were last week's top gainers on the NASDAQ Biotechnology Index.
July 4, 2018
About half way through 2018 finishing the second quarter, the INN takes a look at the 5 top pharma stocks...
June 28, 2018
In the final days of Q2 2018, we've profiled the five top NASDAQ genetic stocks year-to-date. Here's a look at...
April 30, 2018
BIS Research estimates the global blockchain healthcare market will reach $5.61 billion by 2025. Here's a look at how blockchain...
April 29, 2018
Eleven Biotherapeutics, EyePoint Pharmaceuticals, Avid Bioservices, Cerecor and Celldex were last week's top gainers on the NASDAQ.